Abstract
The invention relates to compositions having RGS (regulator of G-protein Signaling) inhibiting activity, and methods of use thereof. In some embodiments, RGS-inhibiting compositions find use in research on or treatment of disease states (e.g., diabetes, epilepsy, neuropathic pain, depression and other diseases).
Original language | English |
---|---|
Patent number | WO2012149335 |
IPC | A61K31/433,A61P25/00,C07D285/08,C07D417/06 |
Priority date | 28/04/11 |
Publication status | Published - 1 Nov 2012 |